Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)

OTCMKTS · Delayed Price · Currency is USD
1.140
0.00 (0.00%)
At close: May 27, 2025
23.91%
Market Cap 1.14B
Revenue (ttm) 920.59M
Net Income (ttm) 108.51M
Shares Out n/a
EPS (ttm) 0.11
PE Ratio 10.46
Forward PE 8.80
Dividend n/a
Ex-Dividend Date n/a
Volume 2,500
Average Volume 3,141
Open 1.140
Previous Close n/a
Day's Range 1.140 - 1.140
52-Week Range 0.931 - 1.430
Beta 0.48
RSI 54.94
Earnings Date Jul 23, 2025

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta... [Read more]

Sector Healthcare
Founded 1996
Employees 1,665
Stock Exchange OTCMKTS
Ticker Symbol GNMLF
Full Company Profile

Financial Performance

In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.

Financial numbers in MXN Financial Statements

News

Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond

The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered MEXICO CITY , June 4, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or...

4 days ago - PRNewsWire

Q1 2025 Genomma Lab Internacional SAB de CV Earnings Call Transcript

Q1 2025 Genomma Lab Internacional SAB de CV Earnings Call Transcript

5 weeks ago - GuruFocus

Genomma Lab Internacional Announces Results for the First Quarter 2025

MEXICO CITY , April 30, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2025.

5 weeks ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call

MEXICO CITY , March 31, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2025 Earnings ...

2 months ago - PRNewsWire

GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT

MEXICO CITY , March 6, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

3 months ago - PRNewsWire

Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024

MEXICO CITY , Feb. 26, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the fourth quarter and full year ended ...

3 months ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2024 Earnings Results Conference Call

MEXICO CITY , Feb. 10, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Fourth Quarter 2024 Earnings ...

4 months ago - PRNewsWire

Genomma Lab Internacional Announces Results for the Third Quarter 2024

MEXICO CITY , Oct. 23, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2024.

8 months ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2024 Earnings Results Conference Call

MEXICO CITY , Oct. 4, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2024 Earnings Re...

8 months ago - PRNewsWire

GENOMMA LAB PHARMA MANUFACTURING FACILITY GRANTED PENDING GMP CERTIFICATION FOR THE MEXICAN MARKET

MEXICO CITY , Oct. 2, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies...

8 months ago - PRNewsWire

GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT

MEXICO CITY , Sept. 10, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B.

9 months ago - PRNewsWire

Genomma Lab Announces Strategic Bolt-On Acquisition of Four Brands

MEXICO CITY, July 25, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V.  (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

11 months ago - PRNewsWire

Genomma Lab Internacional Announces Results for the Second Quarter 2024

MEXICO CITY , July 24, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2024.

11 months ago - PRNewsWire

GENOMMA LAB ANNOUNCES REFINANCING OF LONG-TERM LIABILITIES AND RELEASE OF REAL ESTATE COLLATERAL

MEXICO CITY , July 22, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V . (BMV: LABB) ("Genomma Lab" or "the Company"), a leading company in the pharmaceutical and personal care industry ...

11 months ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference Call

MEXICO CITY , July 2, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Second Quarter 2024 Earnings R...

1 year ago - PRNewsWire

GENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENT

MEXICO CITY , June 13, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

1 year ago - PRNewsWire

Genomma Lab Internacional Announces Results for the First Quarter 2024

MEXICO CITY , April 24, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024.

1 year ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call

MEXICO CITY , April 4, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2024 Earnings R...

1 year ago - PRNewsWire

GENOMMA LAB INTERNACIONAL ANNOUNCES SEVENTH DIVIDEND PAYMENT

MEXICO CITY , March 13, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product compani...

1 year ago - PRNewsWire

Genomma Lab's ESG Rating Upgraded to A

Reflects Third Consecutive Rating Improvement in Four Years MEXICO CITY , Feb. 28, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of t...

1 year ago - PRNewsWire

Genomma Lab Internacional Reports Fourth Quarter & Full Year 2023 Results

"Due to the abrupt devaluation of the Argentine peso in late December, accounting rules required Genomma Lab to record a non-cash negative impact on 4Q23 and full year 2023 earnings. However, excludin...

1 year ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter and Full Year 2023 Earnings Results Conference Call

MEXICO CITY , Jan. 23, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Fourth Quarter and Full Year ...

1 year ago - PRNewsWire

GENOMMA LAB INTERNACIONAL ANNOUNCES SIXTH DIVIDEND PAYMENT

MEXICO CITY , Dec. 13, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

1 year ago - PRNewsWire

Genomma Lab Internacional Reports Third Quarter 2023 Results

MEXICO CITY , Oct. 25, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the third quarter ended September 3...

1 year ago - PRNewsWire

Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2023 Earnings Results Conference Call

MEXICO CITY , Oct. 4, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2023 results on ...

1 year ago - PRNewsWire